Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP66263.RAA02re4DxwGCLR8sVEh38LXafTfVHLn2tGNdGi98VKkA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_predicted type ECO_0000266 NP66263.RAA02re4DxwGCLR8sVEh38LXafTfVHLn2tGNdGi98VKkA130_provenance.
- source_evidence_predicted label "DisGeNET evidence - PREDICTED" NP66263.RAA02re4DxwGCLR8sVEh38LXafTfVHLn2tGNdGi98VKkA130_provenance.
- source_evidence_predicted comment "Gene-disease associations inferred from animal model manually asserted gene-disease associations." NP66263.RAA02re4DxwGCLR8sVEh38LXafTfVHLn2tGNdGi98VKkA130_provenance.
- NP66263.RAA02re4DxwGCLR8sVEh38LXafTfVHLn2tGNdGi98VKkA130_assertion description "[Administration of sodium valproate (VPA), a histone deacetylase 5 (HDAC5) inhibitor, not only significantly relieved the anxiety- and depression-like behaviors of CUS-induced rats but also clearly blunted decrease of H3(K9) and H4(K12) acetylation and expression of TH and TPH, and prevented increase of HDAC5 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP66263.RAA02re4DxwGCLR8sVEh38LXafTfVHLn2tGNdGi98VKkA130_provenance.
- NP66263.RAA02re4DxwGCLR8sVEh38LXafTfVHLn2tGNdGi98VKkA130_assertion evidence source_evidence_predicted NP66263.RAA02re4DxwGCLR8sVEh38LXafTfVHLn2tGNdGi98VKkA130_provenance.
- NP66263.RAA02re4DxwGCLR8sVEh38LXafTfVHLn2tGNdGi98VKkA130_assertion SIO_000772 24495952 NP66263.RAA02re4DxwGCLR8sVEh38LXafTfVHLn2tGNdGi98VKkA130_provenance.
- NP66263.RAA02re4DxwGCLR8sVEh38LXafTfVHLn2tGNdGi98VKkA130_assertion wasDerivedFrom rgd-2016 NP66263.RAA02re4DxwGCLR8sVEh38LXafTfVHLn2tGNdGi98VKkA130_provenance.
- NP66263.RAA02re4DxwGCLR8sVEh38LXafTfVHLn2tGNdGi98VKkA130_assertion wasGeneratedBy ECO_0000218 NP66263.RAA02re4DxwGCLR8sVEh38LXafTfVHLn2tGNdGi98VKkA130_provenance.
- rgd-2016 importedOn "2016-01-25" NP66263.RAA02re4DxwGCLR8sVEh38LXafTfVHLn2tGNdGi98VKkA130_provenance.